Page 45 - Bioscience Inc News Today

Bluejay Diagnostics (NASDAQ:BJDX – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, profitability and institutional ownership. Profitability This table compares Bluejay Diagnostics and INVO Bioscience’s […]

TerrAscend (OTCMKTS:TRSSF – Get Rating) and AppHarvest (NASDAQ:APPH – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, analyst recommendations, institutional ownership and profitability. Profitability This table compares TerrAscend and AppHarvest’s net margins, return on […]

TerrAscend Debuts Cookies And Gage Brands in New Jersey TORONTO, June 2, 2022 /CNW/ – TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a... #cookies #Terrascend #TRSSF

INVO Bioscience, Inc. (NASDAQ:INVO – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 71,800 shares, an increase of 22.5% from the April 30th total of 58,600 shares. Based on an average trading volume of 38,800 shares, the […]

INVO Bioscience (NASDAQ:INVO – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday, Zacks.com reports. The firm currently has a $1.25 target price on the stock. Zacks Investment Research‘s target price would indicate a potential upside of 16.28% from the stock’s current […]

INVO Bioscience (NASDAQ:INVO – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday, Zacks.com reports. According to Zacks, “INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. […]

Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday, Zacks.com reports. The brokerage presently has a $3.00 price objective on the specialty chemicals company’s stock. Zacks Investment Research‘s target price would suggest a […]

Equities Research Analysts’ upgrades for Friday, May 27th: Atlas Air Worldwide (NASDAQ:AAWW) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. AutoNation (NYSE:AN) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. Auto Trader Group (OTCMKTS:ATDRY) was upgraded by analysts at JPMorgan Chase & Co. […]

INVO Bioscience (NASDAQ:INVO – Get Rating) had its price target lowered by stock analysts at Maxim Group to $3.00 in a report issued on Thursday, Stock Target Advisor reports. Maxim Group’s price objective points to a potential upside of 200.00% from the company’s current price. INVO has been the subject of a number of other […]

Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance global […]